Julia Aijun Wang is CFO at BeiGene, Ltd. (BGNE). They have made 12 open-market trades across 1 company since 2021, most recently 2026-02-11.
CIK 0001860279
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 12 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BGNE | SELL | 2024-07-01 | 2024-07-03 | $143.90 | $136K | +2.6% | +9.6% | +55.0% |
| BGNE | SELL | 2024-06-24 | 2024-06-26 | $155.66 | $280K | +1.6% | +14.2% | +47.1% |
| BGNE | SELL | 2024-06-17 | 2024-06-20 | $159.22 | $196K | -6.2% | +4.9% | +28.6% |
| BGNE | SELL | 2024-02-29 | 2024-03-04 | $167.08 | $133K | +3.1% | -7.2% | -10.7% |
| BGNE | SELL | 2023-07-03 | 2023-07-06 | $179.55 | $169K | +2.3% | -1.5% | -11.1% |
| BGNE | SELL | 2023-06-23 | 2023-06-27 | $182.85 | $154K | +8.4% | +17.9% | +7.2% |
| BGNE | SELL | 2023-06-20 | 2023-06-20 | $192.54 | $37K | -6.2% | +1.5% | +9.9% |
| BGNE | SELL | 2023-03-01 | 2023-03-03 | $240.21 | $165K | -2.2% | -11.7% | -7.3% |
| BGNE | SELL | 2022-07-01 | 2022-07-18 | $158.50 | $100K | +1.7% | +4.5% | -3.0% |
| BGNE | SELL | 2022-07-01 | 2022-07-05 | $158.50 | $47K | -6.7% | +0.7% | -27.7% |
| BGNE | SELL | 2022-06-17 | 2022-06-21 | $136.64 | $22K | +12.8% | +27.4% | +4.6% |
| BGNE | SELL | 2021-07-01 | 2021-07-01 | $349.06 | $215K | -4.7% | -6.3% | +3.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.